Ali, AK, Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, USA, United States

• Vol 4, No 2 (2013) - Original Articles
  Pharmacovigilance Analysis of Serious Adverse Events Reported for Biologic Response Modifiers Used as Prophylaxis against Transplant Rejection: a Real-World Postmarketing Experience from the US FDA Adverse Event Reporting System (FAERS)
  Abstract  PDF  XML

---

 pISSN: 2008-6482
 eISSN: 2008-6490

 

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License